Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.
Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Mass.
J Vasc Surg. 2021 Mar;73(3):942-949.e1. doi: 10.1016/j.jvs.2020.07.096. Epub 2020 Aug 27.
After surgery or other interventions, unplanned readmissions are associated with poor outcomes and drain health care resources. Patients with critical limb ischemia (CLI) are at particularly high risk of readmission, and readmissions result in increased health care costs. The primary aims of the study were to discover and compare the 30-day readmission rates of patients who underwent lower extremity surgical bypass (LEB) and endovascular infrainguinal endovascular intervention (IEI) for CLI and to evaluate the relationship between unplanned readmissions likely related to the primary procedure for IEI compared with LEB.
The Targeted Vascular Module from the American College of Surgeons National Surgical Quality Improvement Program was queried to identify all infrainguinal LEB or IEI for CLI from 2015 to 2018. Those who were not eligible for the primary outcome of interest were excluded. The primary 30-day outcome was unplanned readmission. Univariate analyses for primary and secondary outcomes were performed using Fisher's exact and Wilcoxon rank-sum testing. Multivariate analysis was performed using inverse probability weighting and independent risk factors for readmission were identified with logistic regression.
There were 12,873 patients who met inclusion criteria. In the LEB cohort, there were 7270 (56.5%) patients, and in the IEI cohort, there were 5603 (43.5%) patients. Thirty percent (n = 1696) of the IEI cohort underwent a tibial intervention, and 49% (n = 3547) underwent a distal bypass. The IEI cohort was more likely to be high physiologic risk (P < .001) and to present with tissue loss (P < .001), whereas the LEB cohort was more likely to have high anatomic risk features (P < .001) and be performed under emergent conditions (P < .001). After multivariable analysis, LEB was found to be independently predictive for both unplanned readmissions due to any cause (adjusted odds ratio, 1.35; 95% confidence interval, 1.22-1.51; P < .001) and procedure-related unplanned interventions (adjusted odds ratio, 1.85; 95% confidence interval, 1.63-2.11; P < .001). Independent predictors of readmission were LEB, preoperative sepsis, severe chronic kidney disease, dependent functional status, insulin-dependent diabetes mellitus, high-risk physiologic features, African American race, preoperative steroid use, history of severe chronic obstructive pulmonary disease, and preoperative tissue loss.
LEB is independently associated with unplanned readmission from all causes and from procedure-related causes after adjusting for the measured confounders. More research is required to determine the economic burden of these readmissions.
手术后或其他干预措施后,非计划再入院与不良结局相关,并消耗医疗资源。患有严重肢体缺血(CLI)的患者再入院风险特别高,再入院会导致医疗费用增加。本研究的主要目的是发现并比较接受下肢手术旁路(LEB)和血管内腔内血管重建术(IEI)治疗 CLI 的患者的 30 天再入院率,并评估与 IEI 主要手术相关的非计划再入院与 LEB 的关系。
从美国外科医师学院国家外科质量改进计划的靶向血管模块中查询了 2015 年至 2018 年所有用于 CLI 的下肢 LEB 或 IEI。排除不符合主要研究结果的患者。主要 30 天结局是非计划性再入院。使用 Fisher 精确检验和 Wilcoxon 秩和检验对主要和次要结局进行单变量分析。使用逆概率加权进行多变量分析,并使用逻辑回归确定再入院的独立危险因素。
共有 12873 名患者符合纳入标准。在 LEB 组中,有 7270 名(56.5%)患者,在 IEI 组中,有 5603 名(43.5%)患者。IEI 组中有 30%(n=1696)患者接受了胫骨介入治疗,49%(n=3547)患者接受了远端旁路治疗。IEI 组更可能存在高生理风险(P<.001)和组织损失(P<.001),而 LEB 组更可能具有高解剖风险特征(P<.001)和紧急情况下进行手术(P<.001)。多变量分析后发现,LEB 与任何原因导致的非计划性再入院(调整后的优势比,1.35;95%置信区间,1.22-1.51;P<.001)和与手术相关的非计划性干预(调整后的优势比,1.85;95%置信区间,1.63-2.11;P<.001)独立相关。再入院的独立预测因素包括 LEB、术前败血症、严重慢性肾脏病、依赖功能状态、胰岛素依赖型糖尿病、高风险生理特征、非裔美国人种族、术前类固醇使用、严重慢性阻塞性肺疾病史和术前组织损失。
在调整了测量的混杂因素后,LEB 与所有原因和与手术相关的原因导致的非计划性再入院独立相关。需要进一步研究以确定这些再入院的经济负担。